Clinical trial
A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure
NCT00439868 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00439868 |
|---|---|
| Title | A Study To Evaluate The Effect Of WELLBUTRIN XL On Intraocular Pressure |
| Official title | A Cross-over Study to Evaluate the Effect of WELLBUTRIN XL on Intraocular Pressure in Healthy Volunteers |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Depressive Disorder |
| Intervention type | Drug |
| Interventions | WellbutrinXL, placebo |
| Enrollment | 33 |
| Start date | Feb 16, 2007 |
| Primary completion | Jun 8, 2007 |
| Completion | Jun 8, 2007 |
| First posted | Feb 26, 2007 |
| Last update posted | Aug 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: